Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial-Reference-Cited by-同舟云学术

Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial

Published:2016-08 Issue: Volume:178 Page:55-64
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kaul Padma^ORCID,Ohman E. Magnus,Knight J. David,Anstrom Kevin J.,Roe Matthew T.,Boden William E.,Hochman Judith S.,Gašparović Vladimir,Armstrong Paul W.,McCollam Patrick,Fakhouri Walid,Cowper Patricia,Davidson-Ray Linda,Clapp-Channing Nancy,White Harvey D.,Fox Keith A.A.,Prabhakaran Dorairaj,Mark Daniel B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial;Roe;Circ Cardiovasc Qual Outcomes,2012

2. Noninvasive, medical management for non-ST-elevation acute coronary syndromes;Chan;Am Heart J,2008

3. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization;Roe;N Engl J Med,2012

4. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial;Murphy;Eur Heart J,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

2. Pharmacological interventions for heart failure in people with chronic kidney disease;Cochrane Database of Systematic Reviews;2020-02-27

3. Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease;Journal of the American College of Cardiology;2017-12